Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Corbin Eule

Concepts (94)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms
4
2024
972
1.910
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
1998
1.240
Why?
Prostate-Specific Antigen
2
2023
162
0.900
Why?
Carcinoma, Small Cell
1
2024
172
0.820
Why?
Neoplasm Invasiveness
1
2024
504
0.720
Why?
Cisplatin
1
2024
347
0.710
Why?
Urinary Bladder Neoplasms
1
2024
259
0.650
Why?
Neoadjuvant Therapy
1
2024
475
0.650
Why?
Mediastinal Neoplasms
1
2020
54
0.600
Why?
Coombs Test
1
2018
5
0.580
Why?
Anemia, Hemolytic, Autoimmune
1
2018
17
0.570
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2018
78
0.540
Why?
Lymphoma, Large B-Cell, Diffuse
1
2020
195
0.520
Why?
Practice Patterns, Physicians'
1
2024
1408
0.430
Why?
Terminal Care
1
2018
284
0.420
Why?
Pain
1
2018
790
0.380
Why?
Palliative Care
1
2018
1032
0.310
Why?
Doxorubicin
2
2024
416
0.300
Why?
Aged
9
2025
26432
0.300
Why?
Databases, Factual
2
2024
1493
0.280
Why?
Retrospective Studies
5
2024
17438
0.260
Why?
Neoplasms
2
2025
2954
0.260
Why?
Neoplasms, Unknown Primary
1
2025
20
0.220
Why?
Prognosis
2
2024
4351
0.220
Why?
Thiohydantoins
1
2024
5
0.210
Why?
Androstenes
1
2024
16
0.210
Why?
Phenylthiohydantoin
1
2024
44
0.210
Why?
Androgen Receptor Antagonists
1
2024
35
0.210
Why?
Vinblastine
1
2024
75
0.200
Why?
Cystectomy
1
2024
46
0.200
Why?
Peripheral Nervous System Diseases
1
2025
135
0.200
Why?
Androgen Antagonists
1
2024
91
0.200
Why?
Middle Aged
8
2025
36619
0.200
Why?
Aged, 80 and over
3
2025
8391
0.200
Why?
Benzamides
1
2024
226
0.190
Why?
Nitriles
1
2024
212
0.190
Why?
Platinum
1
2023
48
0.190
Why?
Methotrexate
1
2024
234
0.190
Why?
Deoxycytidine
1
2024
219
0.190
Why?
Chemotherapy, Adjuvant
1
2024
429
0.180
Why?
Humans
13
2025
146342
0.170
Why?
Male
9
2025
73396
0.170
Why?
Carcinoma, Renal Cell
1
2023
231
0.160
Why?
Phosphatidylinositol 3-Kinases
1
2022
384
0.160
Why?
Pyrazoles
1
2024
517
0.160
Why?
Proto-Oncogene Proteins c-akt
1
2022
441
0.160
Why?
Carcinoma, Squamous Cell
1
2025
628
0.150
Why?
Etoposide
1
2020
169
0.150
Why?
Vincristine
1
2020
148
0.150
Why?
Cyclophosphamide
1
2020
275
0.150
Why?
TOR Serine-Threonine Kinases
1
2022
455
0.150
Why?
Plasmablastic Lymphoma
1
2019
8
0.140
Why?
Rituximab
1
2020
208
0.140
Why?
Prednisone
1
2020
229
0.140
Why?
Hematologic Tests
1
2018
22
0.140
Why?
Kidney Neoplasms
1
2023
419
0.140
Why?
Bone Cysts
1
2018
12
0.130
Why?
Bone Cements
1
2018
39
0.130
Why?
Paraplegia
1
2018
60
0.130
Why?
Spirituality
1
2018
88
0.130
Why?
Sacrum
1
2018
80
0.130
Why?
Dyspnea
1
2018
251
0.120
Why?
Radiation Injuries
1
2018
149
0.120
Why?
Medical Oncology
1
2018
345
0.110
Why?
Antineoplastic Agents
1
2025
2219
0.100
Why?
Erythrocytes
1
2018
750
0.090
Why?
Decision Making
1
2018
993
0.080
Why?
Autoantibodies
1
2018
1500
0.080
Why?
Female
5
2025
79499
0.060
Why?
Adult
4
2025
41087
0.060
Why?
Vinca Alkaloids
1
2025
6
0.060
Why?
Bridged-Ring Compounds
1
2025
31
0.060
Why?
Microsatellite Instability
1
2025
57
0.050
Why?
Taxoids
1
2025
115
0.050
Why?
Postoperative Complications
1
2018
3034
0.050
Why?
Pharmacogenetics
1
2025
176
0.050
Why?
Young Adult
1
2020
14330
0.050
Why?
B7-H1 Antigen
1
2025
245
0.050
Why?
Anilides
1
2023
83
0.050
Why?
Adolescent
1
2020
22557
0.040
Why?
Genomics
1
2025
853
0.040
Why?
Pyridines
1
2023
610
0.040
Why?
Plasmacytoma
1
2018
19
0.030
Why?
Biomarkers, Tumor
1
2025
1339
0.030
Why?
Genome-Wide Association Study
1
2025
1537
0.030
Why?
Polymorphism, Single Nucleotide
1
2025
2240
0.030
Why?
Disease-Free Survival
1
2019
778
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2023
992
0.030
Why?
Electronic Health Records
1
2025
1210
0.030
Why?
Genetic Predisposition to Disease
1
2025
2488
0.030
Why?
Bone Neoplasms
1
2018
272
0.030
Why?
Survival Rate
1
2019
2092
0.030
Why?
Mutation
1
2025
4093
0.030
Why?
Follow-Up Studies
1
2019
5439
0.020
Why?
Eule's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)